1. OS06.2A Local immunotherapy of glioblastoma via AAV-mediated gene transfer of checkpoint inhibitors in combination with CAR-NK cells. (9th September 2021) Authors: Strecker, M I; Wlotzka, K; Strassheimer, F; Reul, J; Harter, P N; Tonn, T; Steinbach, J P; Wels, W S; Buchholz, C J; Burger, M C Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS12.6.A Combination therapy of CAR-NK-cells and anti-PD-1 results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo. (9th September 2021) Authors: Strassheimer, F; Strecker, M I; Alekseeva, T; Macas, J; Demes, M C; Mildenberger, I C; Tonn, T; Wild, P J; Sevenich, L; Reiss, Y; Harter, P N; Plate, K H; Wels, W S; Steinbach, J P; Burger, M C Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P12.04 Synergistic effects of combination therapy of CAR-NK cells and anti-PD-1 antibody result in high efficacy against advanced stage orthotopic glioblastoma grafts in a syngeneic mouse model and induce protective anti-tumor immunity in vivo. (6th September 2019) Authors: Strassheimer, F; Strecker, M I; Zhang, C; Mildenberger, I C; Harter, P N; Tonn, T; Steinbach, J P; Wels, W S; Burger, M C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗